SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-016691
Filing Date
2024-01-26
Accepted
2024-01-26 16:00:51
Documents
2
Group Members
MEDICXI CO-INVEST IV LPMEDICXI GROWTH CO-INVEST I LPMEDICXI GROWTH I GP LTDMEDICXI IV GP LTDMEDICXI IV LPMEDICXI VENTURES MANAGEMENT (JERSEY) LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d930770dsc13ga.htm SC 13G/A 150163
2 EX-99.1 d930770dex991.htm EX-99.1 11086
  Complete submission text file 0001193125-24-016691.txt   163137
Mailing Address C/O ELIAN FUND SERVICES (JERSEY) LIMITED 44 ESPLANADE ST HELIER Y9 JE4 9WG
Business Address C/O ELIAN FUND SERVICES (JERSEY) LIMITED 44 ESPLANADE ST HELIER Y9 JE4 9WG 44 (0)1534 504343
Medicxi Growth I LP (Filed by) CIK: 0001690310 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9
Type: SC 13G/A

Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Subject) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91182 | Film No.: 24567672
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)